Skip to main content
Top
Published in: Pediatric Rheumatology 1/2022

Open Access 01-12-2022 | Rituximab | Correction

Correction: Successful rituximab treatment for severe rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive juvenile dermatomyositis: a case report and literature review

Authors: Kentaro Nishi, Masao Ogura, Naotaka Tamai, Masafumi Gima, Kentaro Ide, Goro Koinuma, Koichi Kamei, Shuichi Ito

Published in: Pediatric Rheumatology | Issue 1/2022

Login to get access

Excerpt

Correction: Pediatr Rheumatol 20, 60 (2022)
Literature
Metadata
Title
Correction: Successful rituximab treatment for severe rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive juvenile dermatomyositis: a case report and literature review
Authors
Kentaro Nishi
Masao Ogura
Naotaka Tamai
Masafumi Gima
Kentaro Ide
Goro Koinuma
Koichi Kamei
Shuichi Ito
Publication date
01-12-2022
Publisher
BioMed Central
Published in
Pediatric Rheumatology / Issue 1/2022
Electronic ISSN: 1546-0096
DOI
https://doi.org/10.1186/s12969-022-00736-0

Other articles of this Issue 1/2022

Pediatric Rheumatology 1/2022 Go to the issue